Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02266771 · ClinicalTrials.gov registry record · NA
Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice
A NA study, sponsored by LifeBridge Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02266771 is a NA study that has completed, run by LifeBridge Health. The registered enrollment target is 20 participants.
The verdict
NCT02266771, a NA study, has completed, sponsored by LifeBridge Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective to this study is to determine the effectiveness of V.A.C.Veraflo negative pressure wound therapy with instillation, when compared to historical controls of V.A.C Therapy without instillation in the management of wounds.
Interventions
- DEVICE NPWT
- DEVICE NPWT with Instillation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02266771
The ClinicalTrials.gov registry entry for NCT02266771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeBridge Health, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NPWT is the first listed.
NCT02266771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02266771 about?
NCT02266771 is a clinical study titled "Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice". The objective to this study is to determine the effectiveness of V.A.C.Veraflo negative pressure wound therapy with instillation, when compared to historical controls of V.A.C Therapy without instillation in the management of wounds.
What is the current status of trial NCT02266771?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-09. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02266771?
The interventions under investigation include: NPWT (DEVICE), NPWT with Instillation (DEVICE).
Who is sponsoring clinical trial NCT02266771?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.